We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$586B
AUM Growth
-$76.8B
Cap. Flow
-$24.4B
Cap. Flow %
-4.16%
Top 10 Hldgs %
27.57%
Holding
13,842
New
1,775
Increased
5,712
Reduced
4,842
Closed
1,482

Sector Composition

Rank Sector Weight
1 Technology 1.55%
2 Consumer Discretionary 0.95%
3 Financials 0.77%
4 Healthcare 0.67%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICAD
11826
CALL
DELISTED
iCAD Inc
ICAD
$54.8K ﹤0.01%
26,600
+13,200
+99% +$33.6K
SLND icon
11827
Southland Holdings
SLND
$38.2M
$54.4K ﹤0.01%
18,205
+7,740
+74% +$25.1K
ALTG icon
11828
PUT
Alta Equipment Group
ALTG
$200M
$54.4K ﹤0.01%
+11,600
New +$72.4K
IVAC
11829
DELISTED
Intevac Inc
IVAC
$54.3K ﹤0.01%
13,581
-22,262
-62% -$83.8K
OSS icon
11830
PUT
One Stop Systems
OSS
$277M
$54.1K ﹤0.01%
23,300
+1,100
+5% +$3.68K
HMR
11831
Heidmar Maritime Holdings
HMR
$78.5M
$54K ﹤0.01%
+17,477
New +$51.6K
SCNX
11832
Scienture Holdings
SCNX
$16.1M
$53.9K ﹤0.01%
+37,412
New +$117K
NRT
11833
CALL
North European Oil Royalty Trust
NRT
$78.6M
$53.9K ﹤0.01%
+11,200
New +$52.4K
VNDA icon
11834
CALL
Vanda Pharmaceuticals
VNDA
$319M
$53.7K ﹤0.01%
+11,700
New +$54.5K
CRNT icon
11835
CALL
Ceragon Networks
CRNT
$188M
$53.6K ﹤0.01%
22,800
-201,300
-90% -$738K
VTSI icon
11836
CALL
VirTra
VTSI
$34.2M
$53.3K ﹤0.01%
13,100
-103,400
-89% -$618K
SBT
11837
CALL
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$53.2K ﹤0.01%
+11,000
New +$52K
CLIR icon
11838
ClearSign Technologies
CLIR
$32.1M
$53.2K ﹤0.01%
+7,089
New +$70.7K
SKYE icon
11839
Skye Bioscience
SKYE
$8.46M
$53.1K ﹤0.01%
4,172
+2,128
+104% +$46.5K
SENS icon
11840
PUT
Senseonics Holdings Inc
SENS
$488M
$52.9K ﹤0.01%
4,010
+1,260
+46% +$20.8K
LTRN icon
11841
Lantern Pharma
LTRN
$27.4M
$52.9K ﹤0.01%
14,949
-11,352
-43% -$47.1K
AWX icon
11842
Avalon Holdings
AWX
$10.6M
$52.7K ﹤0.01%
18,550
-7,230
-28% -$24.2K
JRVR icon
11843
PUT
James River Group Holdings
JRVR
$193M
$52.5K ﹤0.01%
+12,500
New +$56.8K
NRT
11844
North European Oil Royalty Trust
NRT
$78.6M
$52.5K ﹤0.01%
10,911
-2,124
-16% -$9.94K
SELF
11845
Global Self Storage
SELF
$64.4M
$52.4K ﹤0.01%
10,401
-1,835
-15% -$9.41K
RDZN icon
11846
Roadzen
RDZN
$129M
$52K ﹤0.01%
50,016
+34,009
+212% +$45.7K
FBIO icon
11847
CALL
Fortress Biotech
FBIO
$94.4M
$51.9K ﹤0.01%
+33,300
New +$58.7K
MGNX icon
11848
PUT
MacroGenics
MGNX
$261M
$51.9K ﹤0.01%
40,900
+10,000
+32% +$26.1K
SVC
11849
CALL
Service Properties Trust
SVC
$1.03B
$51.9K ﹤0.01%
+3,980
New +$53.9K
RZLT icon
11850
PUT
Rezolute
RZLT
$487M
$51.9K ﹤0.01%
+17,900
New +$78K

Similar funds

Jeff Yass's Q1 2025 Portfolio in Review

As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.

  • Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
  • Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
  • Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
  • Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
  • Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
  • Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.